scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1012358809 |
P356 | DOI | 10.1007/S13402-012-0071-Y |
P932 | PMC publication ID | 3306558 |
P698 | PubMed publication ID | 22354696 |
P5875 | ResearchGate publication ID | 221851521 |
P50 | author | Peter Bult | Q57159574 |
P2093 | author name string | Patrick W B Derksen | |
Paul J van Diest | |||
Elsken van der Wall | |||
Horst Buerger | |||
Cigdem Ercan | |||
John Hinrichs | |||
Bram van der Ende | |||
P2860 | cites work | Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. | Q53588886 |
Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers. | Q53625030 | ||
The pathologist and breast cancer screening | Q68540308 | ||
Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro | Q68584387 | ||
Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors | Q69502371 | ||
Infiltrating lobular carcinoma of the breast | Q70338114 | ||
Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives | Q72721734 | ||
Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis | Q73299094 | ||
Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer | Q74039261 | ||
Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases | Q77363572 | ||
P53 in breast carcinomas: association between presence of mutation and immunohistochemical expression using a semiquantitative approach | Q77811298 | ||
The price of silent mutations | Q83960871 | ||
Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer | Q84150530 | ||
Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases | Q94153774 | ||
The p53 pathway in breast cancer | Q24802349 | ||
p53 mutations in human cancers | Q28302973 | ||
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database | Q29616468 | ||
Mutations in p53, p53 protein overexpression and breast cancer survival | Q33703486 | ||
Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies | Q34400583 | ||
No consent should be needed for using leftover body material for scientific purposes. For. | Q34872356 | ||
P53 mRNA controls p53 activity by managing Mdm2 functions | Q34927261 | ||
Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice | Q34990925 | ||
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis | Q35168290 | ||
p53 mutations and expression in breast carcinoma in situ | Q35793421 | ||
Prognostic significance of TP53 alterations in breast carcinoma | Q35976693 | ||
The R72P P53 mutation is associated with familial breast cancer in Jewish women | Q36616536 | ||
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis | Q36620640 | ||
European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document | Q37007574 | ||
Mutations in p53 as potential molecular markers for human breast cancer | Q37632816 | ||
Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer | Q38483058 | ||
Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers | Q38487557 | ||
Mutant p53 drives invasion by promoting integrin recycling | Q39753731 | ||
Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas | Q43818075 | ||
P53 codon 72 polymorphism in breast cancer | Q44396389 | ||
Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women | Q44926364 | ||
p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters | Q45574486 | ||
p53 as a specific prognostic factor in triple-negative breast cancer | Q46079292 | ||
The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece | Q46443444 | ||
Pleomorphic variant of invasive lobular carcinoma of the breast | Q46459050 | ||
Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer development | Q46711410 | ||
Role of a p53 polymorphism in the development of human papillomavirus-associated cancer | Q48024470 | ||
Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation | Q48646405 | ||
P433 | issue | 2 | |
P921 | main subject | invasive lobular carcinoma | Q929221 |
P1104 | number of pages | 8 | |
P304 | page(s) | 111-118 | |
P577 | publication date | 2012-02-22 | |
P1433 | published in | Cellular Oncology | Q2160503 |
P1476 | title | p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast | |
P478 | volume | 35 |
Q36468724 | Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study |
Q42577135 | Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses |
Q39285924 | IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes |
Q50923528 | Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma. |
Q33802722 | Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool |
Q35059856 | Lobular breast cancer: molecular basis, mouse and cellular models |
Q38130105 | Lobular breast cancer: pathology, biology, and options for clinical intervention |
Q54317130 | Methylation biomarkers for pleomorphic lobular breast cancer - a short report. |
Search more.